ArticleJournal of nanobiotechnology2026
A CD54-targeted magneto-responsive nanotheranostic for precision treatment of viral pneumonia via CTSB-mediated PANoptosis inhibition.
Jing Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.